Back to Search
BRIAN HALLORAN, MD
MD
Vascular Surgery Physician
NPI: 1205870292Individual
Specialties, Licenses & Credentials
Vascular Surgery PhysicianPrimary
Surgery — Vascular Surgery
Code: 2086S0129X
4301075759(MI)
Research & Publications (20)
Substance P stimulates bone marrow stromal cell osteogenic activity, osteoclast differentiation, and resorption activity in vitro.
PMID 19379851·Bone·2009
7-preclinical
Osteoblast expression of an engineered Gs-coupled receptor dramatically increases bone mass.
PMID 18212126·Proc Natl Acad Sci U S A·2008
7-preclinical
Conditional expression of a Gi-coupled receptor in osteoblasts results in trabecular osteopenia.
PMID 18048501·Endocrinology·2008
7-preclinical
IGF-I receptor is required for the anabolic actions of parathyroid hormone on bone.
PMID 17539737·J Bone Miner Res·2007
7-preclinical
Aging impairs IGF-I receptor activation and induces skeletal resistance to IGF-I.
PMID 17488198·J Bone Miner Res·2007
7-preclinical
Insulin-like growth factor I stimulates recovery of bone lost after a period of skeletal unloading.
PMID 17412794·J Appl Physiol (1985)·2007
4-observational
FGF-10 is decreased in bronchopulmonary dysplasia and suppressed by Toll-like receptor activation.
PMID 17071719·Am J Physiol Lung Cell Mol Physiol·2007
7-preclinical
Role of IGF-I signaling in regulating osteoclastogenesis.
PMID 16939393·J Bone Miner Res·2006
4-observational
Insulin-like growth factor-I is essential for embryonic bone development.
PMID 16857753·Endocrinology·2006
7-preclinical
Optimum substrate size and specific anomer requirements for the reducing-end glycoside hydrolase di-N-acetylchitobiase.
PMID 16794344·Biosci Biotechnol Biochem·2006
7-preclinical
Gender differences in the response of CD-1 mouse bone to parathyroid hormone: potential role of IGF-I.
PMID 16648295·J Endocrinol·2006
7-preclinical
Effects of in vitro bone formation on the mechanical properties of a trabeculated hydroxyapatite bone substitute.
PMID 16514602·J Biomed Mater Res A·2006
7-preclinical
Mutation of a conserved tryptophan in the chitin-binding cleft of Serratia marcescens chitinase A enhances transglycosylation.
PMID 16428843·Biosci Biotechnol Biochem·2006
8-other
Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
PMID 16059637·J Bone Miner Res·2005
7-preclinical
Nop53p is a novel nucleolar 60S ribosomal subunit biogenesis protein.
PMID 15686447·Biochem J·2005
8-other
Hyaluronan increases RANKL expression in bone marrow stromal cells through CD44.
PMID 15619667·J Bone Miner Res·2005
7-preclinical
Lesions of T-cell-mediated kidney allograft rejection in mice do not require perforin or granzymes A and B.
PMID 15084164·Am J Transplant·2004
7-preclinical
Skeletal unloading induces resistance to insulin-like growth factor-I (IGF-I) by inhibiting activation of the IGF-I signaling pathways.
PMID 15040832·J Bone Miner Res·2004
7-preclinical
PTH differentially regulates expression of RANKL and OPG.
PMID 14969393·J Bone Miner Res·2004
7-preclinical
bFGF administration lowers the phosphate threshold for mineralization in bone marrow stromal cells.
PMID 14565596·Calcif Tissue Int·2003
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 5325 ELLIOTT DR, SUITE 104
YPSILANTI, MI 48197 - Phone
- (734) 712-8150
Quick Facts
- NPI
- 1205870292
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile